ArticleSmall science2024
Structurally Tunable Graphitized Mesoporous Carbon for Enhancing the Accessibility and Durability of Cathode Pt-Based Catalysts for Proton Exchange Membrane Fuel Cells.
Article in Small science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Breaking the ORR Trade-Off via Mg-Steered Fe-NSmall (Weinheim an der Bergstrasse, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Low Pt utilization and intense carbon corrosion of cathode catalysts is a crucial issue for high-efficiency proton exchange membrane fuel cells due to the highly demanded long-term durability and less acquisition/application cost. Herein, structurally tunable graphitized mesoporous carbon (GMC) is obtained by direct high-temperature pyrolysis and in situ-controlled mesopore formation; the structure-optimized GMC1300-1800 exhibits a mesopore size of 7.54 nm and enhanced corrosion resistance. Functionalized GMC1300-1800 is loaded with small-sized Pt nanoparticles (NPs) (1.5 nm) uniformly by impregnation method to obtain Pt/GMC1300-1800 and form an "internal platinum structure" to avoid sulfonic acid groups poisoning as well as ensure O
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.